THJ-018
An indazole analogue of JWH-018, a full CB1 and CB2 agonist of nanomolar to subnanomolar affinity.
Harm-reduction warning
No characterised human dose: animal / in vitro data only. Effect profile, safety margin and acute toxicity are not documented in human clinical practice. Extremely potent compound: severe effects, seizures and deaths reported in the literature.
C₂₃H₂₂N₂O
CAS 1364933-55-0
- Family
- Synthetic CB receptor agonistNew psychoactive substance
- Molar mass
- 342.40 g/mol
Updated on
In plain terms
THJ-018 is a variant of JWH-018 in which the indole core is replaced by an indazole. It is a synthetic agonist that binds very strongly to the cannabis receptors in laboratory assays. It is classified as a narcotic in France.
Receptors and activity
Target network
- Activates
The lower the cited value, the closer the target sits to THJ-018: one ring per factor of 100. A target with no measured value stays on the edge.
Where these targets live
Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of THJ-018.
CB1CB1 found in 7 regions of the body
- Basal gangliadenseMost dense in basal ganglia outflow nuclei1
- CerebellumdenseVery dense in the cerebellum1
- HippocampusdenseVery high concentrations in the hippocampus2
- AmygdaladenseHigh concentrations in the amygdala2
- CortexpresentPresent throughout the neocortex2
- Adipose tissuepresentExpressed in adipose tissue3
- GutpresentColonic epithelium, smooth muscle and plexus4
Map sources
- Herkenham M et al. Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A, 1990 (new tab)
- Glass M et al. Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience, 1997 (new tab)
- Engeli S et al. Activation of the peripheral endocannabinoid system in human obesity. Diabetes, 2005 (new tab)
- Wright K et al. Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing. Gastroenterology, 2005 (new tab)
Cited values
- CB1AgonistKi = 5.8 nM · human71 out of 100
Hess et al. 2016, Forensic Toxicol (new tab) · competitive [3H]CP55,940 binding, CHO cell membranes
- CB2AgonistKi = 4.6 nM · human72 out of 100
Hess et al. 2016, Forensic Toxicol (new tab) · competitive [3H]CP55,940 binding, CHO cell membranes
Pharmacology
THJ-018 is a synthetic cannabinoid of the naphthoylindazole family, the direct analogue of JWH-018 in which the indole core is replaced by an indazole core; it was identified in 2014 with its fluorinated analogue THJ-2201 (Diao et al. 2016). Hess et al. (2016) measure on human receptors Ki values of 5.84 nM at CB1 and 4.57 nM at CB2, with activation of both receptors in a cAMP assay. Diao et al. (2016) incubated THJ-018 in human hepatocytes and identified 13 metabolites, the major pathways being hydroxylation of the N-pentyl chain followed by oxidation or glucuronidation, and a dihydrodiol on the naphthalene ring; in human liver microsomes, Gaunitz et al. (2019) describe 33 and note the contribution of CYP2B6, CYP2C19, CYP3A4 and CYP3A5. No controlled study in human beings was found.
Key sources.
- Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol. 2016;34:329-343 (new tab)PMID 27429655
- Diao X, Wohlfarth A, Pang S, Scheidweiler KB, Huestis MA. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes. Clin Chem. 2016;62(1):157-169 (new tab)PMID 26430074
- Gaunitz F, Thomas A, Fietzke M, Franz F, Auwärter V, Thevis M. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation. Int J Legal Med. 2019;133(4):1049-1064 (new tab)PMID 30564916
- Council Framework Decision 2004/757/JHA, consolidated version of 12.01.2026 (annex: substances subject to Union control) (new tab)
History
- Source
- A wholly synthetic molecule, with no natural occurrence. It was identified in 2014, with its fluorinated analogue THJ-2201, as the indazole analogue of JWH-018 (Diao et al. 2016). None of this has anything to do with hemp or with cannabidiol products.
Origin
Laboratory synthesis
No biological pathway: THJ-018 is entirely synthetic and belongs to the chemical family of the naphthoylindazoles.
Legal framework
- European Union
It does not appear in the annex to Framework Decision 2004/757/JHA (consolidated version of 12 January 2026), which names only five synthetic cannabinoid agonists: MDMB-CHMICA, ADB-CHMINACA, CUMYL-4CN-BINACA, MDMB-4en-PINACA and 4F-MDMB-BICA. Nor does it appear in annex III of the consolidated ANSM list (tables I and II of the 1971 Convention on Psychotropic Substances).
- France
A narcotic in France, listed by name: the consolidated ANSM list (updated 16 February 2026) cites in annex IV « THJ-018 ou 1-naphthalenyl (1-pentyl-1H-indazol-3-yl)-methanone », under the family of indazol-3-yl methanones. That family covers molecules bearing on the nitrogen in position 1 of the indazole a substituent of the alkyl, haloalkyl, halobenzyl or related type, and, on the carbon of the methanone bridge, a naphthyl, benzyl, phenyl, cyclopropyl or adamantyl group; the same list cites THJ-2201.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Synthetic CB receptor agonist › New psychoactive substance
- Class
naphtoylindazole
- Verification
Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Hess C, Schoeder CT, Pillaiyar T, Madea B, Müller CE. Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice. Forensic Toxicol. 2016;34:329-343 (new tab)PMID 27429655
- Diao X, Wohlfarth A, Pang S, Scheidweiler KB, Huestis MA. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes. Clin Chem. 2016;62(1):157-169 (new tab)PMID 26430074
- Gaunitz F, Thomas A, Fietzke M, Franz F, Auwärter V, Thevis M. Phase I metabolic profiling of the synthetic cannabinoids THJ-018 and THJ-2201 in human urine in comparison to human liver microsome and cytochrome P450 isoenzyme incubation. Int J Legal Med. 2019;133(4):1049-1064 (new tab)PMID 30564916
- Council Framework Decision 2004/757/JHA, consolidated version of 12.01.2026 (annex: substances subject to Union control) (new tab)
Identifiers
Names
- IUPAC name
- naphthalen-1-yl-(1-pentylindazol-3-yl)methanone
- Other names
- SGT-17
Identifiers
- Formula
- C₂₃H₂₂N₂O
- CAS
- 1364933-55-0
- PubChem CID
- 124518671(new tab)
- InChIKey
- VAKGBPSFDNTMDJ-UHFFFAOYSA-N
- SMILES
- CCCCCN1C2=
CC= CC= C2C(= N1) C(= O) C3= CC= CC4= CC= CC= C43
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.